Baxter International Inc.
BAX Real Time Price USDRecent trades of BAX by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in BAX holdings by institutional investors
Quarterly net insider trading by BAX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$30,000 Jan 06, 2022 Issue: Medicare/Medicaid Health Issues
-
$30,000 Oct 13, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jul 12, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Apr 08, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jan 07, 2021 Issue: Medicare/Medicaid Health Issues
Former government officials who have lobbied for BAX
69 former government officials from 42 congressional offices at 14 lobbying firms have lobbied for BAX, most recently Jul 20, 2026.
-
Jeffrey Lungren House New Special Asst to the President, White House (2008-2009); Dep Asst to the Vice President (2007-2008); Comms Dir, House Judiciary Cmte (2001-2007); Comms Dir, House Science Cmte (1999-2001); Press Sec, Rep. Porter Goss (1997-1998) -
Kate Dickens Senate Chief of Staff, US Sen Mark Kirk; Leg Director, Rep Mike Castle; Foreign Policy Adv, Rep. Connie Morella -
Olivia Kurtz Senate Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle -
Martin Reiser House Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee -
Michael Long House Director of Member Services, Senior Advisor for SpeakerNancy Pelosi; Dep. Floor Director and Advisor, Dem Leader Nancy Pelosi; Special Asst and Staff Asst for Speaker Nancy Pelosi -
Michaeleen Crowell House Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders -
Robert Alspach House Chief Health Counsel for Chairman - House Energy and Commerce Committee (E&C); Counsel - E&C; Clerk - E&C; Paid Intern - E&C
-
Melissa Pfaff Senate Senate HELP: Senior Health Policy Advisor-Ranking Member (RM); Senior Policy Advisor-Chair; Health Policy Advisor-Chair; Prof Staff Member-Chair; Prof Staff Member-RM; Prof Staff Member RM-Senate Budget; Leg Corres-Senate; Staff Assistant-Senate
BAX Estimated quarterly lobbying spending
BAX Revenue by Segment or Geography
New BAX patent grants
-
Patent Title: Infusion pump rack Jun. 13, 2023
-
Patent Title: Syringe pump Jun. 13, 2023
-
Patent Title: Sensor patch Jun. 06, 2023
-
Patent Title: Infusion pump with rechargeable battery Sep. 27, 2022
-
Patent Title: Connector for sensor Sep. 13, 2022
-
Patent Title: Sensor May. 24, 2022
-
Patent Title: Monitor connector Jul. 06, 2021
-
Patent Title: Dual chamber flexible container Oct. 27, 2020
-
Patent Title: Antimicrobial housing and cover for a medical device Jun. 25, 2019
-
Patent Title: Method of operating an infusion pump with a multiple orientation display Apr. 10, 2018
-
Patent Title: Integrated water testing methods for ultra-low total chlorine detection Apr. 10, 2018
-
Patent Title: Systems and methods for intelligent patient interface device Apr. 03, 2018
-
Patent Title: Dialysis machine having auto-connection system with roller occluder Apr. 03, 2018
-
Patent Title: Multi-state alarm system for a medical pump Mar. 27, 2018
-
Patent Title: Renal therapy machine and system including a priming sequence Mar. 27, 2018
-
Patent Title: Non-invasive radio frequency medical fluid level and volume detection system and method Mar. 06, 2018
-
Patent Title: Immobilization of an active agent on a substrate Feb. 20, 2018
-
Patent Title: Dialysis system including automatic priming Feb. 13, 2018
-
Patent Title: Hemodialysis system with cassette-based blood and dialysate pumping Feb. 06, 2018
-
Patent Title: Renal therapy system having pump reversing fluid control Jan. 23, 2018
-
Patent Title: Hemostatic sponge Jan. 23, 2018
-
Patent Title: Optimization of nucleation and crystallization for lyophilization using gap freezing Jan. 16, 2018
-
Patent Title: Catheter/fistula needle to bloodline connection assurance device Jan. 16, 2018
-
Patent Title: Battery management system Jan. 02, 2018
-
Patent Title: Dialysis system including heparin injection Jan. 02, 2018
-
Patent Title: Hemostatic compositions Dec. 05, 2017
-
Patent Title: Non-invasive radio frequency liquid level and volume detection system and method using phase shift Nov. 28, 2017
-
Patent Title: Percutaneous administration device and method for injecting medicinal substances Nov. 28, 2017
-
Patent Title: Nanoclay sorbents for dialysis Nov. 21, 2017
-
Patent Title: Hemostatic compositions Nov. 21, 2017
-
Patent Title: Weight-controlled sorbent system for hemodialysis Nov. 14, 2017
-
Patent Title: Drip chamber with hydrophobic interior surface Oct. 31, 2017
-
Patent Title: Method of controlling medical fluid therapy machine brightness Oct. 24, 2017
-
Patent Title: Blood treatment air purging methods Oct. 24, 2017
-
Patent Title: Pumping systems for cassette-based dialysis Oct. 24, 2017
-
Patent Title: Optical imaging assembly and system with optical distortion correction Oct. 17, 2017
-
Patent Title: Solenoid pinch valve apparatus and method for medical fluid applications having reduced noise production Oct. 10, 2017
-
Patent Title: Peritoneal dialysis systems and methods having graphical user interface Oct. 03, 2017
-
Patent Title: Systems and methods for performing dialysis Sep. 19, 2017
-
Patent Title: Systems and methods for performing hemodialysis Sep. 12, 2017
-
Patent Title: System and method for peritoneal dialysis exchanges having reusable fill and drain containers Sep. 05, 2017
-
Patent Title: Hybrid blood and peritoneal dialysis treatment systems and methods Aug. 29, 2017
-
Patent Title: Automated dialysis system using piston and negative pressure Aug. 29, 2017
-
Patent Title: Dialysis system having non-invasive fluid velocity sensing Aug. 08, 2017
-
Patent Title: Injectable fibrin composition for bone augmentation Aug. 08, 2017
-
Patent Title: Surfactant systems for delivery of organic compounds Jul. 11, 2017
-
Patent Title: Dialysis system having approved therapy prescriptions presented for selection Jul. 04, 2017
-
Patent Title: Methods and apparatus for programming a medical pump Jun. 27, 2017
-
Patent Title: Dialysis treatment prescription system and method Jun. 27, 2017
-
Patent Title: Needleless connector Jan. 24, 2012
Federal grants, loans, and purchases
Estimated quarterly amount awarded to BAX from public contracts
Recent insights relating to BAX
Recent picks made for BAX stock on CNBC
ETFs with the largest estimated holdings in BAX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $BAX stock a Buy, Sell, or Hold?
- What is the price target for $BAX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $BAX stock?
- Who owns the most shares of $BAX stock?
- What funds own $BAX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BAX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
- Address Deerfield, IL
- Market Cap 12.1 billion
- Employees 37,500
- Industrial Classification Surgical & Medical Instruments & Apparatus
Baxter International Inc. (BAX) Historical Stock Prices
Daily open, high, low, close, adjusted close and volume for Baxter International Inc. (BAX).
Quiver Premium charts BAX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver APIWe estimate that -- received a compensation of -- in --, making them the highest paid executive at BAX, per a recent SEC DEF 14A filing. We estimate that the median employee at BAXTER INTERNATIONAL INC is paid $70,331.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|